Nimesulida Farmoz (Nimesulide)

Nimesulide works by selectively inhibiting the cyclooxygenase‑2 (COX‑2) enzyme, which is responsible for converting arachidonic acid into prostaglandins that mediate pain, fever, and inflammation. By reducing COX‑2 activity, the drug lowers prostaglandin production, providing analgesic and anti‑inflammatory effects while sparing COX‑1–related gastric protection.

The exact dose of Nimesulida Farmoz is determined by the prescribing clinician based on the patient’s age, weight, indication, and renal or hepatic function. Healthcare professionals follow local prescribing guidelines and adjust the regimen as needed; patients should not alter the dose without medical advice.

Nimesulide is generally avoided during pregnancy, especially in the third trimester, because of potential risks to the fetus and mother. Limited data are available for breastfeeding, and the drug may pass into breast milk; therefore, use is discouraged unless the benefit clearly outweighs the risk and a physician approves it.

To order Nimesulida Farmoz, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Nimesulide is a selective COX‑2 inhibitor, which may offer a lower risk of gastrointestinal irritation compared with non‑selective NSAIDs such as ibuprofen or diclofenac. However, its hepatic safety profile requires monitoring, and it is not interchangeable with acetyl‑salicylic acid or naproxen, which have different risk‑benefit balances.

Store Nimesulida Farmoz below 25 °C in its original packaging, protecting it from moisture and direct sunlight. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

Nimesulida Farmoz is taken orally, usually with a full glass of water. It may be taken with or without food, but patients who experience stomach upset are advised to take it with meals. The tablet should be swallowed whole and not crushed or chewed.

The most serious risks include hepatotoxicity, which can progress to liver failure, severe skin reactions such as Stevens‑Johnson syndrome, gastrointestinal bleeding or ulcer perforation, and renal impairment. Patients should be educated to seek immediate medical attention if they notice jaundice, severe rash, abdominal pain, or unexplained bleeding.

Nimesulida Farmoz should be avoided in patients with known hypersensitivity to nimesulide or other NSAIDs, those with active peptic ulcer disease, severe hepatic or renal impairment, uncontrolled heart failure, and in the third trimester of pregnancy. It is also contraindicated in individuals taking other COX‑2 inhibitors or certain anticoagulants without medical supervision.